VANCOUVER, British Columbia, February 28, 2012 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Applied Materials (NASDAQ:AMAT), ATP Oil & Gas (NASDAQ:ATPG), Boston Scientific (NYSE:BSX), Delta Air Lines (NYSE:DAL), and Human Genome Sciences (NASDAQ:HGSI).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Report Highlights:
Applied Materials, Inc. (NASDAQ:AMAT): By the end of Monday's trading, Applied Materials, Inc. (NASDAQ:AMAT) slid 0.79% to US$12.53 with heavier than usual volume traded. The move occurred on volume of 15.75 million which is relative to the 15.51 million shares traded on average each day. Share prices of Applied Materials, Inc. have traded as high as US$16.93 per share and as low as US$9.70 in the past 52 weeks. Pennystocksinsiders.com thinks that it is a clever way to check if insiders like CEOs, CFOs, and Directors in AMAT are starting to buy more company shares. See insider trade report for AMAT here.
Read Full Report: http://www.Pennystocksinsiders.com/PR/022812B/AMAT/AppliedMaterials.pdf
ATP Oil & Gas Corporation (NASDAQ:ATPG): ATP Oil & Gas Corporation (NASDAQ:ATPG) announced yesterday it successfully had first oil production from the fourth well at its Telemark Hub. In addition, ATP Oil & Gas Corporation recently announced that an estimated 2011 full-year proved and probable pre-tax PV-10 of about US$7.3 billion, 52% increase from 2010. The company's estimated average production for 2011 full-year was about 24.6 thousand barrels per day, 17% increase from 2010. The stock share prices jumped18.96% on Monday to US$8.47 with heavy volume which was 6.6 times more than usual. Are insiders starting to take huge profits by selling shares or exercising stock options? Add ATPG into your watch list for insider trade now.
Read Full Report: http://www.Pennystocksinsiders.com/PR/022812B/ATPG/ATPOilGas.pdf
Boston Scientific Corporation (NYSE:BSX): Pennystocksinsiders.com found Market Purchase made by company Independent Director - Ernest Mario on February 23, at stock price US$5.91. Disclose date: February 27. Boston Scientific Corporation (NYSE:BSX) has recently received US Food and Drug Administration approval for use of its Ion and Taxus Liberete stents in heart attack patients. Investors may want to find out how company insiders like Executive Officers and Directors are thinking about the future business prospects of the company. Check this insider trade report for BSX here.
Read Full Report: http://www.Pennystocksinsiders.com/PR/022812B/BSX/BostonScientific.pdf
Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Delta Air Lines, Inc. (NYSE:DAL):
Read Full Report: http://www.Pennystocksinsiders.com/PR/022812B/DAL/DeltaAirLines.pdf
Human Genome Sciences (NASDAQ:HGSI):
Read Full Report: http://www.Pennystocksinsiders.com/PR/022812B/HGSI/HumanGenome.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
About Pennystocksinsiders.com:
Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Important Disclaimer:
Please visit Pennystocksinsiders.com/disclaimers/index.php for details.
